These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 630884)

  • 1. Mid-trimester abortion induced by intravaginal administration of prostaglandin F2 alpha-methylester suppositories.
    van den Bergh AS; Haspels AA
    Contraception; 1978 Feb; 17(2):141-51. PubMed ID: 630884
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful first trimester abortion with 15(S) 15-methyl-prostaglandin F2alpha-methyl ester vaginal suppositories.
    Borell U; Bygdeman M; Leader A; Lundström V; Martin JN
    Contraception; 1976 Jan; 13(1):87-94. PubMed ID: 1245121
    [No Abstract]   [Full Text] [Related]  

  • 3. Vaginal administration of 15 (S) 15-methyl prostaglandin F2 alpha methyl ester for induction of mid-trimester abortion.
    Grech ES; Chatterjee TK; Niles L
    Contraception; 1977 Oct; 16(4):327-37. PubMed ID: 923245
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of 15(s)15-methyl-PGF2alpha-methyl ester vaginal suppositories on circulating hormone levels in early pregnancy.
    Puri CP; Laumas V; Agarwal N; Zoremthangi ; Hingorani V; Laumas KR
    Prostaglandins; 1977 Feb; 13(2):363-73. PubMed ID: 847240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between intraamniotic PGF2 alpha and vaginal PGE2 for second-trimester abortion.
    Lebed JP; Rubin A; Millman AE
    Obstet Gynecol; 1980 Jul; 56(1):90-6. PubMed ID: 7383493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mid-trimester abortion induced by intravaginal administration of prostaglandin E2 suppositories.
    Lauersen NH; Secher NJ; Wilson KH
    Am J Obstet Gynecol; 1975 Aug; 122(8):947-54. PubMed ID: 1155530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical dilation with prostaglandin F2 alpha for first trimester abortion.
    Natrajan PK; Tzingounis VA
    South Med J; 1986 Jul; 79(7):830-1. PubMed ID: 3460179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new abortion technique: intravaginal and intramuscular prostaglandin.
    Lauersen NH; Den T; Scher J; Iliescu C; Wilson KH
    Obstet Gynecol; 1981 Jul; 58(1):96-100. PubMed ID: 7243150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interruption of first trimester pregnancy by prostaglandins.
    Bygdeman M; Green K; Lundström V
    Int J Gynaecol Obstet; 1977; 15(1):69-72. PubMed ID: 923898
    [No Abstract]   [Full Text] [Related]  

  • 10. Second-trimester abortion by intramuscular 15-methyl-prostaglandin F2 alpha or intravaginal prostaglandin E2 suppositories: a randomized trial.
    Borgida AF; Rodis JF; Hanlon W; Craffey A; Ciarleglio L; Campbell WA
    Obstet Gynecol; 1995 May; 85(5 Pt 1):697-700. PubMed ID: 7724098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of 15(S) 15-methyl-PGF 2 alpha-methyl ester vaginal suppositories for cervical dilatation and second trimester pregnancy termination.
    Krishna UR; Mhatre V; Ganguli AC; Purandare VN
    Contraception; 1976 Dec; 14(6):661-70. PubMed ID: 1017200
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of 15 (S) 15 methyl-PGF 2 alpha methyl ester suppositories with a two dose schedule for termination of early pregnancy.
    Zoremthangi B; Agarwal N; Puri CP; Laumas KR; Hingorani V
    Contraception; 1976 Nov; 14(5):519-27. PubMed ID: 975834
    [No Abstract]   [Full Text] [Related]  

  • 13. 15(S)15-methyl prostaglandin F2alpha for termination of very early human pregnancy. A comparative study of a single intramuscular injection and vaginal suppositories.
    Fylling P; Jerve F
    Prostaglandins; 1977 Oct; 14(4):785-90. PubMed ID: 339283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a vaginal suppository suitable for single administration for interruption of second trimester pregnancy.
    Bygdeman M; Ganguli A; Kinoshita K; Lundström V; Green K; Bergström S
    Contraception; 1977 Feb; 15(2):129-41. PubMed ID: 837687
    [No Abstract]   [Full Text] [Related]  

  • 15. Midtrimester abortion induced by serial intravaginal administration of prostaglandin E2 suppositories in conjunction with a contraceptive diaphragm.
    Lauersen NH; Wilson KH
    Prostaglandins; 1975 Jul; 10(1):139-50. PubMed ID: 1153798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of abortion by vaginal administration of 15(s)15-methyl prostaglandin F2alpha methyl ester. A comparison of two delivery systems.
    Bygdeman M; Gréen K; Lundström V; Ramadan M; Fotiou S; Bergström S
    Prostaglandins; 1976; 12 Suppl():27-51. PubMed ID: 968064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical application of prostaglandins in obstetrics and gynecology.
    Brunnberg FJ
    Acta Biol Med Ger; 1976; 35(8-9):1243-7. PubMed ID: 1007783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of cervical resistance by prostaglandin suppositories prior to dilatation for induced abortion.
    Dingfelder JR; Brenner WE; Hendricks CH; Staurovsky LG
    Am J Obstet Gynecol; 1975 May; 122(1):25-30. PubMed ID: 1130444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of a 10 cm2, 0.5% 15-ME-PGF2alpha methyl ester intravaginal silastic device on abortion and plasma prostaglandin concentration.
    Lauersen NH; Wilson KH
    Prostaglandins; 1977 Apr; 13(4):755-62. PubMed ID: 857275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mid-trimester abortion with intra-amniotic prostaglandin F2 alpha and intravenous oxytocin infusion.
    Salomy M; Halbrecht I; London R
    Prostaglandins; 1975 Feb; 9(2):271-9. PubMed ID: 1135439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.